Politics Judge rejects Trump’s request to delay trial in rape accuser Carroll’s lawsuit The Cheap InvestorApril 17, 2023April 17, 20230 By Luc Cohen NEW YORK (Reuters) -A U.S. judge on Monday rejected former President Donald Trump’s request to delay a…
BusinessEconomy Ryanair does not expect major disruption due to Boeing issues The Cheap InvestorApril 17, 2023April 17, 20230 DUBLIN (Reuters) – Ryanair does not expect to see major disruption this summer on account of Boeing’s decision to halt…
AsiaBusiness HSBC shareholder Ping An to vote for bank’s break-up at annual meeting -source The Cheap InvestorApril 17, 2023April 17, 20230 HONG KONG/LONDON (Reuters) – HSBC’s biggest shareholder Ping An is likely to vote in favour of splitting the bank up…
BusinessEconomy BoE to raise rates once more in May but decision a close call – Reuters poll The Cheap InvestorApril 17, 2023April 17, 20230 By Shaloo Shrivastava BENGALURU (Reuters) – The Bank of England likely has one more hike in its tightening cycle but…
HeadlinesReuters Charles Schwab Beats Profit Estimates On Higher Rates; Deposits Drop The Cheap InvestorApril 17, 20230 (Corrects deposit figures in paragraph 6 to “billion” from “million”) (Reuters) -Charles Schwab Corp beat first-quarter profit estimates as rate…
BusinessEconomy Swiss government awards $9.7 million contract related to Credit Suisse – UBS merger The Cheap InvestorApril 17, 2023April 17, 20230 By Oliver Hirt ZURICH (Reuters) – The Swiss government has awarded an advisory mandate worth up to 8.7 million Swiss…
BusinessEconomy German oil imports rose 8.5% in 2022, Russia biggest supplier The Cheap InvestorApril 17, 20230 FRANKFURT (Reuters) – Germany’s crude oil imports rose 8.5% in 2022 as Europe’s biggest economy recovered from the COVID-19 pandemic…
BusinessEconomy New York factory activity rebounds in April-NY Fed The Cheap InvestorApril 17, 2023April 17, 20230 WASHINGTON (Reuters) – The New York Federal Reserve said on Monday its barometer of manufacturing activity in New York State…
BusinessHealth Merck to take $10.3 billion R&D charge for Prometheus deal this year The Cheap InvestorApril 17, 2023April 17, 20230 (Reuters) – Merck & Co expects a research-and-development charge of about $10.3 billion, or $4 per share, this year as…
BusinessHealth US Supreme Court spurns Sanofi appeal to revive EpiPen suit against Viatris The Cheap InvestorApril 17, 2023April 17, 20230 By John Kruzel WASHINGTON (Reuters) -The U.S. Supreme Court on Monday declined to hear a bid by Sanofi SA to…